Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ANALOGIC CORP
Report date October 31, 2016 · Filed November 02, 2016
Section 16 reporting ended · disclosed 2016-11-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,837 |
Ending reported balance
After 2016-10-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-10-31 · Exercise / conversion · Acquired 2,469 · Balance 27,000 F1: Represents the accelerated vesting of one-third of the 7,408 time-based restricted stock units ("RSUs") granted on 9/10/15 in connection with the grantee's resignation as an officer of Analogic Corporation (the "Company") effective October 31, 2016, which converted into common stock of the Company on a 1:1 basis. The remainder of the RSU grant was cancelled effective October 31, 2016. Row 2 · 2016-10-31 · Tax withholding · Disposed 1,163 · Balance 25,837 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,949 |
Reported balance
After 2016-10-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-10-31 · Exercise / conversion · Disposed 2,469 · Balance 4,949 F1: Represents the accelerated vesting of one-third of the 7,408 time-based restricted stock units ("RSUs") granted on 9/10/15 in connection with the grantee's resignation as an officer of Analogic Corporation (the "Company") effective October 31, 2016, which converted into common stock of the Company on a 1:1 basis. The remainder of the RSU grant was cancelled effective October 31, 2016. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2016-10-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-10-31 · Disposition to issuer · Disposed 4,939 · Balance 0 F1: Represents the accelerated vesting of one-third of the 7,408 time-based restricted stock units ("RSUs") granted on 9/10/15 in connection with the grantee's resignation as an officer of Analogic Corporation (the "Company") effective October 31, 2016, which converted into common stock of the Company on a 1:1 basis. The remainder of the RSU grant was cancelled effective October 31, 2016. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,246 |
Reported balance
After 2016-10-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2016-10-31 · Disposition to issuer · Disposed 3,749 · Balance 11,246 F2: Represents forfeiture of performance based RSUs granted on 9/08/14 in connection with the grantee's resignation as an officer of the Company effective October 31, 2016. The remaining RSUs will vest based on the Company's performance as determined following the performance period, which ends on July 31, 2017. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,449 |
Reported balance
After 2016-10-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2016-10-31 · Disposition to issuer · Disposed 7,628 · Balance 5,449 F3: Represents forfeiture of performance based RSUs granted on 9/10/15 in connection with the grantee's resignation as an officer of the Company effective October 31, 2016. The remaining RSUs will vest based on the Company's performance as determined following the performance period, which ends on July 31, 2018 F2: Represents forfeiture of performance based RSUs granted on 9/08/14 in connection with the grantee's resignation as an officer of the Company effective October 31, 2016. The remaining RSUs will vest based on the Company's performance as determined following the performance period, which ends on July 31, 2017. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,217 |
Reported balance
After 2016-10-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2016-10-31 · Disposition to issuer · Disposed 13,390 · Balance 1,217 F4: Represents forfeiture of performance based RSU's granted on 9/15/16 in connection with the grantee's resignation as an officer of the Company effective October 31, 2016. The remaining RSUs will vest based on the Company's performance as determined following the performance period, which ends on July 31, 2019. F3: Represents forfeiture of performance based RSUs granted on 9/10/15 in connection with the grantee's resignation as an officer of the Company effective October 31, 2016. The remaining RSUs will vest based on the Company's performance as determined following the performance period, which ends on July 31, 2018 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the accelerated vesting of one-third of the 7,408 time-based restricted stock units ("RSUs") granted on 9/10/15 in connection with the grantee's resignation as an officer of Analogic Corporation (the "Company") effective October 31, 2016, which converted into common stock of the Company on a 1:1 basis. The remainder of the RSU grant was cancelled effective October 31, 2016.
F2: Represents forfeiture of performance based RSUs granted on 9/08/14 in connection with the grantee's resignation as an officer of the Company effective October 31, 2016. The remaining RSUs will vest based on the Company's performance as determined following the performance period, which ends on July 31, 2017.
F3: Represents forfeiture of performance based RSUs granted on 9/10/15 in connection with the grantee's resignation as an officer of the Company effective October 31, 2016. The remaining RSUs will vest based on the Company's performance as determined following the performance period, which ends on July 31, 2018
F4: Represents forfeiture of performance based RSU's granted on 9/15/16 in connection with the grantee's resignation as an officer of the Company effective October 31, 2016. The remaining RSUs will vest based on the Company's performance as determined following the performance period, which ends on July 31, 2019.
HARVARD BIOSCIENCE INC
Report date August 15, 2025 · Filed August 19, 2025
Section 16 reporting ended · disclosed 2025-08-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,796,040 |
Reported balance
After 2025-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-08-15 · Disposition to issuer · Disposed 49,048 · Balance 2,796,040 F1: Represents forfeiture of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 6, 2023 in connection with the Reporting Person resigning from all services with the Issuer. |
| Common StockSEC Table I · non-derivative | Direct | 2,762,840 |
Reported balance
After 2025-08-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-08-15 · Tax withholding · Disposed 33,200 · Balance 2,762,840 F2: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with an RSU award previously granted to the Reporting Person that vested on August 15, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 2,643,508 |
Reported balance
After 2025-08-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2025-08-15 · Disposition to issuer · Disposed 119,332 · Balance 2,643,508 F3: Represents forfeiture of time-based RSUs granted to the Reporting Person on March 5, 2024 in connection with the Reporting Person resigning from all services with the Issuer. |
| Common StockSEC Table I · non-derivative | Direct | 2,631,968 |
Reported balance
After 2025-08-15 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2025-08-15 · Tax withholding · Disposed 11,540 · Balance 2,631,968 F4: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with an RSU award previously granted to the Reporting Person that vested on August 15, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 2,565,905 |
Reported balance
After 2025-08-15 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2025-08-15 · Disposition to issuer · Disposed 66,036 · Balance 2,565,905 F5: Represents forfeiture of performance-based RSUs granted to the Reporting Person on March 6, 2023 in connection with the Reporting Person resigning from all services with the Issuer. |
| Common StockSEC Table I · non-derivative | Direct | 2,452,566 |
Reported balance
After 2025-08-15 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2025-08-15 · Disposition to issuer · Disposed 113,366 · Balance 2,452,566 F6: Represents forfeiture of performance-based RSUs granted to the Reporting Person on March 5, 2024 in connection with the Reporting Person resigning from all services with the Issuer. F7: This total includes 375,005 RSUs with performance based vesting conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents forfeiture of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 6, 2023 in connection with the Reporting Person resigning from all services with the Issuer.
F2: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with an RSU award previously granted to the Reporting Person that vested on August 15, 2025.
F3: Represents forfeiture of time-based RSUs granted to the Reporting Person on March 5, 2024 in connection with the Reporting Person resigning from all services with the Issuer.
F4: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with an RSU award previously granted to the Reporting Person that vested on August 15, 2025.
F5: Represents forfeiture of performance-based RSUs granted to the Reporting Person on March 6, 2023 in connection with the Reporting Person resigning from all services with the Issuer.
F6: Represents forfeiture of performance-based RSUs granted to the Reporting Person on March 5, 2024 in connection with the Reporting Person resigning from all services with the Issuer.
F7: This total includes 375,005 RSUs with performance based vesting conditions.
OSI SYSTEMS INC
Report date July 05, 2019 · Filed July 08, 2019
Section 16 reporting ended · disclosed 2019-07-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,831 |
Reported balance
After 2019-07-05 transaction · row 1
1 source rowRow 1 · 2019-07-05 · Tax withholding · Disposed 233 · Balance 3,831 F1: Pursuant with a net settlement, shares of stock were tendered to satisfy tax withholding obligations. No shares of stock were sold. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant with a net settlement, shares of stock were tendered to satisfy tax withholding obligations. No shares of stock were sold.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2025 Filed Aug 19, 2025 18:39 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Disposition to issuerCommon Stock | 113,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-080209 · tm2523890-1_4seq1.xml · nonDerivative · entry 6 Green James W · CIK 0001400121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,452,566 F6 · shares: Represents forfeiture of performance-based RSUs granted to the Reporting Person on March 5, 2024 in connection with the Reporting Person resigning from all services with the Issuer. F7 · balance_after: This total includes 375,005 RSUs with performance based vesting conditions. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 18:39 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Disposition to issuerCommon Stock | 66,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-080209 · tm2523890-1_4seq1.xml · nonDerivative · entry 5 Green James W · CIK 0001400121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,565,905 F5 · shares: Represents forfeiture of performance-based RSUs granted to the Reporting Person on March 6, 2023 in connection with the Reporting Person resigning from all services with the Issuer. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 18:39 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 11,540 | $0.53 | $6,104.66 |
DisclosureSEC source: 0001104659-25-080209 · tm2523890-1_4seq1.xml · nonDerivative · entry 4 Green James W · CIK 0001400121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,631,968 F4 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with an RSU award previously granted to the Reporting Person that vested on August 15, 2025. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 18:39 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Disposition to issuerCommon Stock | 119,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-080209 · tm2523890-1_4seq1.xml · nonDerivative · entry 3 Green James W · CIK 0001400121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,643,508 F3 · shares: Represents forfeiture of time-based RSUs granted to the Reporting Person on March 5, 2024 in connection with the Reporting Person resigning from all services with the Issuer. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 18:39 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 33,200 | $0.53 | $17,562.80 |
DisclosureSEC source: 0001104659-25-080209 · tm2523890-1_4seq1.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,762,840 F2 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with an RSU award previously granted to the Reporting Person that vested on August 15, 2025. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 18:39 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Disposition to issuerCommon Stock | 49,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-080209 · tm2523890-1_4seq1.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,796,040 F1 · shares: Represents forfeiture of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 6, 2023 in connection with the Reporting Person resigning from all services with the Issuer. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:49 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 38,413 | $0.69 | $26,451.19 |
DisclosureSEC source: 0001104659-25-026702 · tm259984-1_4seq1.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,845,088 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit ("RSU") awards previously granted to the Reporting Person that vested on March 19, 2025. F2 · balance_after: Includes (a) 117,713 RSUs that will vest on December 29, 2025, (b) 143,198 RSUs that will vest in two equal installments on March 19, 2026 and 2027, (c) 554,407 RSUs with performance based vesting conditions and (d) 2,029,770 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:15 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Disposition to issuerCommon Stock | 145,365 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-25-000025 · form412799001_01032025.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,883,501 F1 · shares: Represents forfeiture of performance-based restricted stock units ("RSUs") granted to the Reporting Person on March 1, 2022 based on the final determination of the applicable performance conditions. F2 · balance_after: Includes (a) 117,713 RSUs that will vest on December 29, 2025, (b) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (c) 554,407 RSUs with performance based vesting conditions and (d) 1,996,584 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| December 29, 2024 Filed Dec 31, 2024 21:02 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 25,310 | $1.98 | $50,113.80 |
DisclosureSEC source: 0000921895-24-003052 · form412799001gre_12312024.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,028,866 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit ("RSU") awards previously granted to the Reporting Person that vested on December 29, 2024. F2 · balance_after: Includes (a) 117,713 RSUs that will vest on December 29, 2025, (b) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (c) 699,772 RSUs with performance based vesting conditions and (d) 1,996,584 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| December 29, 2024 Filed Dec 31, 2024 21:02 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 56,915 | $1.98 | $112,691.70 |
DisclosureSEC source: 0000921895-24-003052 · form412799001gre_12312024.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,054,176 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit ("RSU") awards previously granted to the Reporting Person that vested on December 29, 2024. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:02 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 10,000 | $2.91 | $29,100.00 |
DisclosureSEC source: 0000921895-24-001418 · form412799001_06142024.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,111,091 F1 · balance_after: Includes (a) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 RSUs that will vest on December 29, 2024, (c) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (d) 699,772 RSUs with performance based vesting conditions and (e) 1,908,749 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:02 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 20,000 | $3.07 | $61,400.00 |
DisclosureSEC source: 0000921895-24-001362 · form412799001_06072024.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,101,091 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.03 to $3.12, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 RSUs that will vest on December 29, 2024, (c) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (d) 699,772 RSUs with performance based vesting conditions and (e) 1,898,749 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:03 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 214,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-24-000333 · e619331_4-green.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,081,091 F2 · shares: The number of RSUs represents the target number of RSUs that may be earned based on achievement by the Company of certain performance criteria. The actual number of RSUs awarded may vary between 0% and 150% of the target, depending on the Company's performance. The performance period will end on December 31, 2026. F3 · balance_after: Includes (a) the awards described in footnotes (1) and (2) above, (b) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (c) 52,346 RSUs that will vest on December 29, 2024, (d) 484,975 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 1,878,749 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:03 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 214,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-24-000333 · e619331_4-green.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866,294 F1 · shares: Represents an award of restricted stock units ("RSUs") that will vest in three equal installments on March 19, 2025, 2026, and 2027. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:18 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 82,790 | $5.35 | $442,926.50 |
DisclosureSEC source: 0000921895-24-000043 · form412799001gre_01032024.xml · nonDerivative · entry 5 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,651,497 F2 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that vested on December 31, 2023. F3 · balance_after: Includes (a) 235,427 restricted stock units that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 restricted stock units that will vest on December 29, 2024, (c) 484,975 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (d) 1,878,749 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 22:18 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 52,206 | $5.35 | $279,302.10 |
DisclosureSEC source: 0000921895-24-000043 · form412799001gre_01032024.xml · nonDerivative · entry 4 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,734,287 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the Reporting Person that vested on December 29, 2023. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 22:18 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 23,216 | $5.35 | $124,205.60 |
DisclosureSEC source: 0000921895-24-000043 · form412799001gre_01032024.xml · nonDerivative · entry 3 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,786,493 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the Reporting Person that vested on December 29, 2023. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 22:18 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 28,783 | $5.35 | $153,989.05 |
DisclosureSEC source: 0000921895-24-000043 · form412799001gre_01032024.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809,709 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the Reporting Person that vested on December 29, 2023. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 22:18 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 24,187 | $5.35 | $129,400.45 |
DisclosureSEC source: 0000921895-24-000043 · form412799001gre_01032024.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,838,492 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the Reporting Person that vested on December 29, 2023. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 20:06 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 25,000 | $4.38 | $109,500.00 |
DisclosureSEC source: 0000921895-23-002050 · form412799gre_08212023.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,862,679 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.35 to $4.40, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) 353,140 restricted stock units that will vest in three equal installments on December 29, 2023, 2024 and 2025, (b) 104,691 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024, (c) 64,899 restricted stock units that will vest on December 29, 2023, (d) 54,535 restricted stock units that will vest on December 29, 2023, (e) 671,649 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (f) 1,613,765 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| June 11, 2023 Filed Jun 13, 2023 20:02 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 48,373 | $5.46 | $264,116.58 |
DisclosureSEC source: 0000921895-23-001485 · form412799gre_06132023.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,837,679 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on June 11, 2023. F2 · balance_after: Includes (a) 353,140 restricted stock units that will vest in three equal installments on December 29, 2023, 2024 and 2025, (b) 104,691 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024, (c) 64,899 restricted stock units that will vest on December 29, 2023, (d) 54,535 restricted stock units that will vest on December 29, 2023, (e) 671,649 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (f) 1,588,765 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 22:35 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 20,000 | $2.60 | $52,000.00 |
DisclosureSEC source: 0000921895-23-000690 · form412799gre_03152023.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,886,052 F3 · price: This transaction was executed in multiple trades at prices ranging from $2.57 to $2.63, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, and (b) the shares purchased in the transaction described in footnote (3) above. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 22:35 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 20,000 | $2.67 | $53,400.00 |
DisclosureSEC source: 0000921895-23-000690 · form412799gre_03152023.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,866,052 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.61 to $2.70, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) the shares described in footnote (1) above, (b) 353,140 restricted stock units that will vest in three equal installments on December 29, 2023, 2024 and 2025, (c) 104,691 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024, (d) 109,071 restricted stock units that will vest on June 11, 2023, (e) 64,899 restricted stock units that will vest on December 29, 2023, (f) 54,535 restricted stock units that will vest on December 29, 2023, (g) 671,649 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (h) 1,488,067 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:02 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 339,610 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-23-000668 · form412799gre_03082023.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,846,052 F3 · shares: Represents an award of 339,610 restricted stock units with performance based vesting conditions. These restricted stock units will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from March 1, 2023 to the earlier of (i) December 31, 2025, and (ii) the date of a change of control (the "Measurement Period"), measured relative to the Russell 2000 index and based on the 20-day trading average beginning on the first day of the Measurement Period and ending on the last day of the Measurement Period, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 22:02 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 353,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-23-000668 · form412799gre_03082023.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,506,442 F1 · shares: Represents an award of 353,140 restricted stock units that will vest in three equal installments on December 29, 2023, 2024 and 2025, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) 104,691 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024, (c) 109,071 restricted stock units that will vest on June 11, 2023, (d) 64,899 restricted stock units that will vest on December 29, 2023, (e) 54,535 restricted stock units that will vest on December 29, 2023, (f) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (g) 1,488,067 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:14 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 49,322 | $2.77 | $136,621.94 |
DisclosureSEC source: 0000921895-23-000012 · form412799gre_01032023.xml · nonDerivative · entry 4 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,153,302 F7 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that vested on January 1, 2023. F8 · balance_after: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnotes (3), (5) and (7) above. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 23:14 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 23,216 | $2.55 | $59,200.80 |
DisclosureSEC source: 0000921895-23-000012 · form412799gre_01032023.xml · nonDerivative · entry 3 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,202,624 F5 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2022. F6 · balance_after: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnotes (3) and (5) above. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 23:14 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 28,784 | $2.55 | $73,399.20 |
DisclosureSEC source: 0000921895-23-000012 · form412799gre_01032023.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,225,840 F3 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2022. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 23:14 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 24,187 | $2.55 | $61,676.85 |
DisclosureSEC source: 0000921895-23-000012 · form412799gre_01032023.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,254,624 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person that vested in part on December 29, 2022. F2 · balance_after: Includes (a) 104,691 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024, (b) 109,071 restricted stock units that will vest on June 11, 2023, (c) 64,899 restricted stock units that will vest on December 29, 2023, (d) 54,535 restricted stock units that will vest on December 29, 2023, (e) 104,590 restricted stock units that will vest on January 1, 2023, (f) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (g) 1,484,799 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:01 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 15,000 | $2.61 | $39,150.00 |
DisclosureSEC source: 0000921895-22-003154 · form412799gre_12022022.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,278,811 F3 · price: This transaction was executed in multiple trades at prices ranging from $2.55 to $2.70, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, and (b) the shares purchased in the transaction described in footnote (3) above. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:01 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 15,000 | $2.41 | $36,150.00 |
DisclosureSEC source: 0000921895-22-003154 · form412799gre_12022022.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,263,811 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.31 to $2.45, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) the shares described in footnote (1) above, (b) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (c) 109,071 remaining restricted stock units that will vest on June 11, 2023, (d) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (e) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (f) 104,590 remaining restricted stock units that will vest on January 1, 2023, (g) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (h) 1,307,205 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:19 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 40,000 | $3.19 | $127,600.00 |
DisclosureSEC source: 0000921895-22-002497 · form412799001_08182022.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248,811 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.14 to $3.23, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) the shares described in footnote (1) above, (b) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (c) 109,071 remaining restricted stock units that will vest on June 11, 2023, (d) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (e) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (f) 104,590 remaining restricted stock units that will vest on January 1, 2023, (g) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (h) 1,267,205 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 20:03 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 92,771 | $3.90 | $361,806.90 |
DisclosureSEC source: 0000921895-22-002223 · form412799001_07122022.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,208,811 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on July 8, 2022. F2 · balance_after: Includes (a) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 109,071 remaining restricted stock units that will vest on June 11, 2023, (c) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 104,590 remaining restricted stock units that will vest on January 1, 2023, (f) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (g) 1,267,205 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:00 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 30,000 | $3.71 | $111,300.00 |
DisclosureSEC source: 0000921895-22-002024 · form412799001_06162022.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,301,582 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.68 to $3.74, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) the shares described in footenote (1) above, (b) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (c) 109,071 remaining restricted stock units that will vest on June 11, 2023, (d) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (e) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (f) 104,590 remaining restricted stock units that will vest on January 1, 2023, (g) 541,218 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (h) 1,120,797 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| June 11, 2022 Filed Jun 14, 2022 20:07 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 48,373 | $3.95 | $191,073.35 |
DisclosureSEC source: 0000921895-22-001986 · form412799001gre_06142022.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,271,582 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on June 11, 2022. F2 · balance_after: Includes (a) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 109,071 remaining restricted stock units that will vest on June 11, 2023, (c) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 104,590 remaining restricted stock units that will vest on January 1, 2023, (f) 541,218 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (g) 1,120,797 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| May 09, 2022 Filed May 10, 2022 21:13 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 10,000 | $3.40 | $34,000.00 |
DisclosureSEC source: 0000921895-22-001555 · form412799001_05102022.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,319,955 F3 · price: This transaction was executed in multiple trades at prices ranging from $3.375 to $3.41, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, and (b) the shares purchased in the transaction described in footnote (3) above. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:13 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 30,000 | $3.78 | $113,400.00 |
DisclosureSEC source: 0000921895-22-001555 · form412799001_05102022.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,309,955 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.705 to $3.845, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 218,140 remaining restricted stock units that will vest on June 11, 2022 and 2023, (c) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 104,590 remaining restricted stock units that will vest on January 1, 2023, (f) 541,218 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (g) 1,050,101 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:13 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 145,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-22-000419 · e621405_4-james.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,279,955 F3 · shares: Represents an award of 145,365 restricted stock units with performance based vesting conditions. These restricted stock units will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from March 1, 2022 to the earlier of (i) December 31, 2024, and (ii) the date of a change of control (the "Measurement Period"), measured relative to the Russell 2000 index and based on the 20-day trading average beginning on the first day of the Measurement Period and ending on the last day of the Measurement Period, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 02:13 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 157,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-22-000419 · e621405_4-james.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,134,590 F1 · shares: Represents an award of 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) 218,140 remaining restricted stock units that will vest on June 11, 2022 and 2023, (c) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 104,590 remaining restricted stock units that will vest on January 1, 2023, (f) 395,853 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (g) 1,020,101 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:48 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 47,424 | $7.05 | $334,339.20 |
DisclosureSEC source: 0000921895-22-000032 · form412799gre_01032022.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,977,554 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on January 1, 2022. F2 · balance_after: Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (c) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (d) 104,590 remaining restricted stock units that will vest on January 1, 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 810,919 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:17 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Disposition to issuerCommon Stock | 28,783 | $7.27 | $209,252.41 |
DisclosureSEC source: 0000921895-21-002905 · form412799001gre_12302021.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,024,978 F3 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on December 29, 2021. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:17 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Disposition to issuerCommon Stock | 24,187 | $7.27 | $175,839.49 |
DisclosureSEC source: 0000921895-21-002905 · form412799001gre_12302021.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,053,761 F1 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on December 29, 2021. F2 · balance_after: Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (c) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (d) 209,180 remaining restricted stock units that will vest on January 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 782,536 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:35 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GiftCommon Stock | 13,777 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-21-002678 · form412799001_11152021.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,077,948 F1 · balance_after: Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 194,698 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 163,606 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (d) 209,180 remaining restricted stock units that will vest on January 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 687,288 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:24 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | SaleCommon Stock | 48,175 | $8.02 | $386,363.50 |
DisclosureSEC source: 0000921895-21-002200 · form412799001_08252021.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,091,725 F1 · price: This transaction was executed in multiple trades at prices ranging from $7.97 to $8.10, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 194,698 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 163,606 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (d) 209,180 remaining restricted stock units that will vest on January 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 701,065 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 20:54 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 92,772 | $8.03 | $744,959.16 |
DisclosureSEC source: 0000921895-21-001842 · form412799001_07122021.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,139,900 F3 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on July 8, 2021. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 20:54 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 107,803 | $8.03 | $865,658.09 |
DisclosureSEC source: 0000921895-21-001842 · form412799001_07122021.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,232,672 F1 · shares: The shares were disclosed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock award previously granted to the Reporting Person that vested in full on July 8, 2021. F2 · balance_after: Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 194,698 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 163,606 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (d) 209,180 remaining restricted stock units that will vest on January 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 842,012 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 22:17 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Tax withholdingCommon Stock | 48,373 | $7.64 | $369,569.72 |
DisclosureSEC source: 0000921895-21-001647 · form412799gre_06152021.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,340,475 F3 · shares: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with the performance restricted stock unit award previously granted to the Reporting Person that vested in part on June 11, 2021. F4 · balance_after: Includes (a) the shares and awards described in footnote (2) above, less (b) the disposition of shares reported in footnote (3) above. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 22:17 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 109,070 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-21-001647 · form412799gre_06152021.xml · nonDerivative · entry 1 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,388,848 F1 · shares: On June 11, 2020, the Reporting Person was granted an award of 218,141 restricted stock units with performance based vesting conditions, which vest in equal installments on June 11, 2021, 2022 and 2023, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from June 11, 2020 to the earlier of (i) June 11, 2021 or (ii) upon a change of control (measured relative to the Nasdaq Biotechnology index). The target number of the restricted stock units that may be earned was reported on the date of grant; the maximum amount is 150% of the number then reported. As a result of the Issuer's performance based on such performance targets, the Reporting Person earned 150% of the target amount, subject to continuation of employment through the remaining vesting dates. Accordingly, the reported transaction reflects the acquisition of 109,070 additional performance restricted stock units earned above the target grant. F2 · balance_after: Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 194,698 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, (c) 163,606 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (c) 243,072 restricted stock units that will fully vest on July 8, 2021, (d) 209,180 remaining restricted stock units that will vest on January 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 755,116 shares of common stock beneficially owned by the Reporting Person. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:26 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | Exercise / conversionStock option (right to buy) · Derivative | 24,312 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0000921895-21-001485 · form412799001_05252021.xml · derivative · entry 3 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,690 Underlying: Common Stock · 24,312 shares Expires 2027-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vest in four equal installments on December 31, 2020, 2021, 2022 and 2023. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:26 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | SaleCommon Stock | 24,312 | $7.14 | $173,587.68 |
DisclosureSEC source: 0000921895-21-001485 · form412799001_05252021.xml · nonDerivative · entry 2 Green James W · CIK 0001400121 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,279,778 F2 · price: This transaction was executed in multiple trades at prices ranging from $7.04 to $7.20, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes (a) the shares and awards described in footnote (1) above, less (b) the disposition of shares reported in footnote (2) above. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.